Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat
about
Resveratrol and clinical trials: the crossroad from in vitro studies to human evidenceAkt/FOXO3a/SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: switching gears toward survival and longevityModulation of Hypercholesterolemia-Induced Oxidative/Nitrative Stress in the HeartMammalian sirtuins: biological insights and disease relevanceConfronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work.Sodium tanshinone IIA sulfonate protects rat myocardium against ischemia-reperfusion injury via activation of PI3K/Akt/FOXO3A/Bim pathway.Crosstalk between the DNA damage response, histone modifications and neovascularisation.Protective effects of Xinji'erkang on myocardial infarction induced cardiac injury in miceAdeno-sh-beta-catenin abolishes ischemic preconditioning-mediated cardioprotection by downregulation of its target genes VEGF, Bcl-2, and survivin in ischemic rat myocardium.Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism.Cellular and mitochondrial effects of alcohol consumption.Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection.Ethanolic Extract of Vitis thunbergii Exhibits Lipid Lowering Properties via Modulation of the AMPK-ACC Pathway in Hypercholesterolemic Rabbits.Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium.Resveratrol, wine, and atherosclerosis.Resveratrol protects against diet-induced atherosclerosis by reducing low-density lipoprotein cholesterol and inhibiting inflammation in apolipoprotein E-deficient mice.Targeting the mitochondria to augment myocardial protection.High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury.Myocardial AKT: the omnipresent nexus.Resveratrol attenuates cortical neuron activity: roles of large conductance calcium-activated potassium channels and voltage-gated sodium channels.Bromelain induces cardioprotection against ischemia-reperfusion injury through Akt/FOXO pathway in rat myocardium.Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase.Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor.A review of complementary and alternative approaches to immunomodulation.Type 2 diabetes, mitochondrial biology and the heart.Secoisolariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia-reperfusion injury in hypercholesterolemic myocardium.Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: role of VEGF/angiopoietin-1Integrative medicine in gastrointestinal disease: evaluating the evidence.Hibernating myocardium: pathophysiology, diagnosis, and treatment.Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease.Hyperlipidaemia induced by a high-cholesterol diet leads to the deterioration of guanosine-3',5'-cyclic monophosphate/protein kinase G-dependent cardioprotection in ratsResveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis.Antiobesity and vasoprotective effects of resveratrol in apoE-deficient miceResveratrol activates endogenous cardiac stem cells and improves myocardial regeneration following acute myocardial infarction.Regulation of SIRT1 in cellular functions: role of polyphenolsAnti-atherogenic effects of resveratrol.Therapeutic neovascularization for coronary disease: current state and future prospects.Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.Most appropriate animal models to study the efficacy of statins: a systematic review.An overview of the efficacy of resveratrol in the management of ischemic heart disease.
P2860
Q24618313-98025869-FD0B-4FCA-B0C4-3F3B227A6B5BQ24647370-1AACA75B-B12F-419A-A442-21EC67603B19Q26770809-70F788B5-6750-41C4-9DF7-6CD1B3561F71Q29614496-3DDCB934-46B0-4B15-BC3C-7CC944577531Q30379206-A3031759-D54A-4F72-9FE6-A52AEE311110Q33551875-7CC4DFE5-03A6-4686-BA4F-9833AD8C40E1Q33639330-1CD7B8C1-34C4-4B9B-80A3-DA5DCAD60F64Q33836713-BAB89902-2097-4DAE-A0AA-031BA8395092Q34100145-D8EE8427-899A-45C9-9255-44C6450EA1CDQ34531697-AD19B450-DABF-4FC0-B969-38D737CDAE1BQ34566111-56E8C6C8-9BF3-4E03-882A-806EC69F5389Q35017049-C539FB52-CF37-42F0-92D2-19D51409F93CQ35872279-8BEA1DD6-E139-49F4-8629-B7CFCDBBABC1Q35886665-BE405EF5-1302-47A2-AD8A-0B6EB8504306Q36238935-17E49054-AD20-49AE-AF26-C4DB318692D5Q36608631-8E87717E-2CBF-4DEA-9BEA-EC22C7104A43Q36613672-21B5F72A-21D5-4F58-86AF-990AAD266C2AQ36776148-E8372FCD-928F-47B7-AF70-94F6B91695BFQ36908289-70F4EF0E-9152-4CA8-9054-4A3DD36A13AFQ36923476-C67498CB-B4AF-44EF-8A9A-B6C8A2BE5F7EQ36969204-35628933-9E14-4578-AFAE-8B372E3BA83AQ36980730-F3E232E7-62A2-41FD-B689-D1B316A808DEQ36984711-34368078-703A-404B-AB0B-B29C2BC838D7Q37060108-263DF6A0-B622-4605-B4DC-C86B07B49264Q37195072-10D80779-EC9F-4B02-8D89-73C128D848ACQ37226354-C2A792D8-9CEF-4381-BA95-6A98C29EDCEFQ37310691-C4359E48-996E-499D-A9B7-A6598E7D76E5Q37345889-0FEBBC8D-F8A4-484C-BF85-A44EAE2A327FQ37445512-69719BC2-1DB2-4876-B02C-B25A09987451Q37445518-95E5DB4E-F778-4A6F-B29A-116709F1EC83Q37481201-A6B8A7A7-A74B-4C1D-99D9-ADA762CE3C8DQ37613474-94331E32-5185-480E-BD53-C72A6D3E29BEQ37653755-D201173B-71E4-4D49-963C-2FA2BAD0E276Q37722141-3BAEB162-BC36-4088-8600-E51155339EA1Q37745178-C55A57D9-7766-4829-A831-305A3A98C823Q37756520-E5862713-AC0A-4D95-83EA-487650208FF9Q37895528-9CF6917E-7939-4D56-9E17-1CF459019C48Q37971308-9CE2122E-A1D2-4731-9745-2849A66A4080Q38234426-0A75B049-1799-4637-84A1-C454A8C03DC8Q38557902-F4F8E81E-B2EE-4A4D-B1C1-692A5F47CECA
P2860
Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Statin and resveratrol in comb ...... on in hypercholesterolemic rat
@ast
Statin and resveratrol in comb ...... on in hypercholesterolemic rat
@en
type
label
Statin and resveratrol in comb ...... on in hypercholesterolemic rat
@ast
Statin and resveratrol in comb ...... on in hypercholesterolemic rat
@en
prefLabel
Statin and resveratrol in comb ...... on in hypercholesterolemic rat
@ast
Statin and resveratrol in comb ...... on in hypercholesterolemic rat
@en
P2093
P2860
P1476
Statin and resveratrol in comb ...... on in hypercholesterolemic rat
@en
P2093
Bela Juhasz
Hajime Otani
Lijun Zhan
Mahesh Thirunavukkarasu
Nilanjana Maulik
Srikanth Koneru
Suresh Varma Penumathsa
Venugopal P Menon
P2860
P304
P356
10.1016/J.YJMCC.2006.10.018
P577
2006-12-26T00:00:00Z